Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that ...

D Bioprinting Market. The global 3D bioprinting market is projected to reach USD 2.24 billion by 2024, with demand expected ...

The research extends the functional capabilities of nanozymes, shifting the focus from small molecule substrates to complex ...

The global dental soft-tissue regeneration market is projected to reach USD 0.54 billion by 2029 from USD 0.37 Billion in ...

ProgenaCare is a purpose-driven medical device company leveraging cutting-edge advances in biomaterials and medical device technologies to provide effective, affordable advanced wound care solutions ...

BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyve TM Antimicrobial Wound Gel reflects BioStem’s continued commitment to building a diverse ...

With outstanding achievements in biotechnology, Dr Nguyen Thuy Ba Linh from University College London (UCL) has become the ...

Scientists have transformed blood into a substance which successfully repaired bones in animals, paving the way for ...

The immune system has developed the ability to effectively heal small ruptures and fractures by regulating the regenerative ...

Dr. Nguyen Thuy Ba Linh, a university lecturer in the UK, has become the first Vietnamese scientist to be honored at the ...